Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
Crossref DOI link: https://doi.org/10.1007/s00262-014-1562-7
Published Online: 2014-06-04
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pretto, Francesca
Elia, Giuliano
Castioni, Nadia
Neri, Dario
Text and Data Mining valid from 2014-06-04